SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2005 / Cilt: 5 - Sayı: 4

Koroner arter hastalarında yüksek dansiteli lipoprotein kolesterol: Beklendiği kadar düşük mü?

High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected?

Mehmet UZUNLULU
Aytekin OĞUZ
Kürşat TİGEN
Pages
268–270
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Coronary artery disease group consisted of those patients with any atherosclerotic lesions in coronary angiography, and non-CAD group consisted of patients with no such lesions.Results: Average HDL cholesterol levels were 45.0±10.5 mg/dl (44.4±10.9 mg/dl in men, 46.5±9.6 mg/dl in women) in CAD group, and 47.7±9.0 mg/dl (45.5±8.4 mg/dl in men, 48.9±9.2 mg/dl in women) in non-CAD group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Epidemiological studies demonstrate that the high-density lipoprotein (HDL) cholesterol levels in Turkish people are lower compared to other populations.
📊
Key Findings & Data:In the present study, the HDL cholesterol levels in subjects with or without angiographically documented coronary artery disease (CAD) were compared to assess whether HDL cholesterol levels were as low as expected.Methods: A total of 420 consecutive patients with age of ≥40 years (160 female, 260 male) undergoing coronary angiography were included in the study.
💡
Conclusion & Impact:Coronary artery disease group consisted of those patients with any atherosclerotic lesions in coronary angiography, and non-CAD group consisted of patients with no such lesions.Results: Average HDL cholesterol levels were 45.0±10.5 mg/dl (44.4±10.9 mg/dl in men, 46.5±9.6 mg/dl in women) in CAD group, and 47.7±9.0 mg/dl (45.5±8.4 mg/dl in men, 48.9±9.2 mg/dl in women) in non-CAD group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Epidemiological studies demonstrate that the high-density lipoprotein (HDL) cholesterol levels in Turkish people are lower compared to other populations. In the present study, the HDL cholesterol levels in subjects with or without angiographically documented coronary artery disease (CAD) were compared to assess whether HDL cholesterol levels were as low as expected.Methods: A total of 420 consecutive patients with age of ≥40 years (160 female, 260 male) undergoing coronary angiography were included in the study. Patients receiving fibric acid derivatives or niacin were excluded. Coronary artery disease group consisted of those patients with any atherosclerotic lesions in coronary angiography, and non-CAD group consisted of patients with no such lesions.Results: Average HDL cholesterol levels were 45.0±10.5 mg/dl (44.4±10.9 mg/dl in men, 46.5±9.6 mg/dl in women) in CAD group, and 47.7±9.0 mg/dl (45.5±8.4 mg/dl in men, 48.9±9.2 mg/dl in women) in non-CAD group (p

Özet

Amaç: Epidemiyolojik çalışmalar Türk halkında yüksek dansiteli lipoprotein (HDL) kolesterol düzeylerinin diğer toplumlardan daha düşük olduğunu göstermektedir. Bu çalışmada HDL kolesterol düzeylerinin beklendiği kadar düşük olup olmadığını saptamak amacıyla, anjiyografik olarak koroner arter hastalığı (KAH) bulunan ve bulunmayan hastalardaki HDL kolesterol düzeyleri karşılaştırıldı.Yöntemler: Çalışmaya koroner anjiyografileri yapılmış olan 40 yaş ve üzeri toplam 420 hasta (160 kadın, 260 erkek) ardışık olarak alındı. Fibrik asit türevleri ve niyasin kullanan hastalar çalışmaya alınmadı. Koroner anjiyografide herhangi bir aterosklerotik lezyon saptanan hastalar KAH bulunan grubu, herhangi bir lezyon saptanmayan hastalar KAH bulunmayan grubu oluşturdu.Bulgular: Çalışmamızda, HDL kolesterol ortalaması KAH bulunan grupta 45.0±10.5 mg/dl (erkeklerde 44.4±10.9 mg/dl, kadınlarda 46.5±9.6 mg/dl) , KAH bulunmayan grupta 47.7±9.0 mg/dl (erkeklerde 45.5±8.4 mg/dl, kadınlarda 48.9±9.2 mg/dl) idi (p

🔖

Cite This Article

UZUNLULU, M., OĞUZ, A., TİGEN, K. (2022). Koroner arter hastalarında yüksek dansiteli lipoprotein kolesterol: Beklendiği kadar düşük mü?. Anadolu Kardiyoloji Dergisi, Cilt: 5 - Sayı: 4, 268–270. https://ajindex.com/articles/437377

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996;124 (Suppl): S11-20
  2. Sacks FM. Expert Group on HDL Cholesterol. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol 2002; 90:139-43
  3. Mahley RW, Palaoglu KE, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36: 839-59
  4. Onat A, Yıldırım B, Uslu N, et al. Plasma lipoprotein and apolipoproteins in Turkish adults: overall levels, association with risk factors, and HDL as a predictor of coronary risk in women. Arch Turk Soc Cardiol 1999; 27:72-9
  5. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
  6. Rubins HB, Robins SJ, Collins D, et al. Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. Am J Cardiol 1995; 75: 1196- 201
  7. McLaughlin PR, Gladstone P. Diabetes Atherosclerosis Intervention Study (DAIS): quantitative coronary angiographic analysis of coronary artery atherosclerosis. Cathet Cardiovasc Diagn 1998; 44: 249-56
  8. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999; 34: 410-8
  9. Elam MB, Hunninghake DB, Davis KB, et al. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial. JAMA 2000; 284: 1263-70
  10. MRC/BHF Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J 1999; 20: 725-41
  11. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Res